Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers
Avantor, Inc. (AVTR)
Last avantor, inc. earnings: 4/29 04:05 pm
Check Earnings Report
Company Research
Source: PR Newswire
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customersRADNOR, Pa., May 10, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, and Cytovance Biologics, Inc., a biologics contract development and manufacturing organization specializing in the manufacturing of high-quality plasmid DNA have entered into an agreement to manufacture research and GMP grade plasmids for biopharma customers. This collaboration extends Avantor's leadership in providing critical materials for next-generation vaccines and therapeutics focused on cell and gene therapy and mRNA drug manufacturing and expands Cytovance Biologics' global commercial reach.Plasmid DNA is one of the most critical process elements in viral vector-based gene therapy and mRNA vaccines a
Show less
Read more
Impact Snapshot
Event Time:
AVTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVTR alerts
High impacting Avantor, Inc. news events
Weekly update
A roundup of the hottest topics
AVTR
News
- Avantor® to Participate in BofA Securities 2024 Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Avantor® to Participate in BofA Securities 2024 Health Care ConferencePR Newswire
- Avantor, Inc. (NYSE:AVTR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down [Yahoo! Finance]Yahoo! Finance
- Avantor, Inc. (NYSE: AVTR) had its price target lowered by analysts at Robert W. Baird from $27.00 to $26.00. They now have an "outperform" rating on the stock.MarketBeat
AVTR
Earnings
- 4/26/24 - Beat
AVTR
Sec Filings
- 4/26/24 - Form 10-Q
- 4/26/24 - Form 8-K
- 4/18/24 - Form 4
- AVTR's page on the SEC website